Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen

被引:19
作者
Hsu, HY
Chang, MH
Hsieh, RP
Ni, YH
Chi, WK
机构
[1] NATL TAIWAN UNIV,COLL MED,DEPT EMERGENCY MED,TAIPEI 10764,TAIWAN
[2] NATL TAIWAN UNIV,COLL MED,DEPT PEDIAT,TAIPEI 10764,TAIWAN
[3] NATL TAIWAN UNIV,COLL MED,DEPT LAB MED,TAIPEI 10764,TAIWAN
[4] DEV CTR BIOTECHNOL,TAIPEI,TAIWAN
关键词
D O I
10.1002/hep.510240607
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The immune responses to hepatitis B vaccine were studied in 11 hepatitis B surface antigen (HBsAg) carrier children who had cleared HBsAg but failed to develop hepatitis B surface antigen antibodies (anti-HBs) in sera (group 1), 5 HBsAg carrier children who had cleared HBsAg and developed detectable anti-HBs in sera (group 2), and 5 healthy subjects seronegative for all hepatitis B virus (HBV) markers (group 3), After receiving three doses of HB vaccine, group 1 subjects failed to develop detectable anti-HBs, Subsequently, each subject of the three groups was given one dose of the same vaccine for a cellular immunity study, and a measurable proliferation of peripheral blood mononuclear cells (PBMC) to HBsAg was detected in 1 of 8 (12.5%), 0 of 5, and 4 of 5 (80%) of the cases in each group, respectively, after vaccination, The removal of CD8(+) cells enhanced the HBsAg blastogenic response in group 3 but did not reverse the unresponsiveness in group 1 and group 2 subjects, The addition of interleukin (IL)-2 in culture reversed unresponsiveness in all cases except one case in group 1, Compared with before vaccination, PBMC from group 2 subjects produced significantly less interferon gamma (IFN-gamma) and more IL-4 in response to HBsAg after vaccination, a cytokine response not observed in group 1 subjects, HLA typing indicated that 3 of 10 patients in group 1 (30%) and 1 of 5 patients in group 2 (20%) had HLA-DRw14-DRw52, a marker previously linked to low anti-HBs response to hepatitis B vaccine in Taiwan, We conclude that the underlying causes of poor anti-HBs response in group 1 subjects are multifactorial, including specific failure of antigen presentation or T-cell activation, or the lack of T helper (Th)2 cell-like response to HBsAg, HLA-DRw14-DRw52 does not confer absolute nonresponsiveness to HBsAg, These patients are not benefited by hepatitis B immunization.
引用
收藏
页码:1355 / 1360
页数:6
相关论文
共 50 条
  • [31] Hepatitis B virus DNA and hepatitis B surface antigen levels in chronic hepatitis B
    Fung, James
    Lai, Ching-Lung
    Yuen, Man-Fung
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2010, 8 (06) : 717 - 726
  • [32] FACTORS AFFECTING CLEARANCE OF HEPATITIS-B E-ANTIGEN IN HEPATITIS-B SURFACE-ANTIGEN CARRIER CHILDREN
    CHANG, MH
    SUNG, JL
    LEE, CY
    CHEN, CJ
    CHEN, JS
    HSU, HY
    LEE, PI
    CHEN, DS
    JOURNAL OF PEDIATRICS, 1989, 115 (03) : 385 - 390
  • [33] IMMUNE-RESPONSE TO HEPATITIS B SURFACE ANTIGEN
    IBRAHIM, AB
    VYAS, GN
    PERKINS, HA
    INFECTION AND IMMUNITY, 1975, 11 (01) : 137 - 141
  • [34] Hepatitis B caused by a hepatitis B surface antigen escape mutant
    Eiji Kajiwara
    Yasuhito Tanaka
    Tomoko Ohashi
    Kotarou Uchimura
    Seizo Sadoshima
    Mitsuru Kinjo
    Masashi Mizokami
    Journal of Gastroenterology, 2008, 43 : 243 - 247
  • [35] Hepatitis B caused by a hepatitis B surface antigen escape mutant
    Kajiwara, Eiji
    Tanaka, Yasuhito
    Ohashi, Tomoko
    Uchimura, Kotarou
    Sadoshima, Seizo
    Kinjo, Mitsuru
    Mizokami, Masashi
    JOURNAL OF GASTROENTEROLOGY, 2008, 43 (03) : 243 - 247
  • [36] NECROSIS OF HEPATOCYTES WITH HEPATITIS-B SURFACE-ANTIGEN - OCCURRENCE IN A CHRONIC HEPATITIS-B SURFACE-ANTIGEN CARRIER
    KARASAWA, T
    SHIKATA, T
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1977, 101 (06) : 280 - 285
  • [37] Clinical features of chronic hepatitis B patients with low hepatitis B surface antigen levels and determinants of hepatitis B surface antigen seroclearance
    Taniguchi, Hideaki
    Iwasaki, Yoshiaki
    Aimi, Masahito
    Shimazaki, Gaku
    Moriya, Akio
    JGH OPEN, 2020, 4 (04): : 698 - 706
  • [38] Hepatitis B surface antigen monitoring and management of chronic hepatitis B
    Sonneveld, M. J.
    Zoutendijk, R.
    Janssen, H. L. A.
    JOURNAL OF VIRAL HEPATITIS, 2011, 18 (07) : 449 - 457
  • [39] Cytokine and hepatitis B virus DNA co-immunizations enhance cellular and humoral immune responses to the middle but not to the large hepatitis B virus surface antigen in mice
    Geissler, M
    Schirmbeck, R
    Reimann, J
    Blum, HE
    Wands, JR
    HEPATOLOGY, 1998, 28 (01) : 202 - 210
  • [40] NEONATAL HEPATITIS IN 5 CHILDREN OF A HEPATITIS-B SURFACE-ANTIGEN CARRIER WOMAN
    MOLLICA, F
    MUSUMECI, S
    FISCHER, A
    JOURNAL OF PEDIATRICS, 1977, 90 (06) : 949 - 951